News
Duality Biotherapeutics' ('DualityBio', HKEX:09606) partner Avenzo Therapeutics, Inc. ('Avenzo'), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback